Your browser doesn't support javascript.
loading
Undetectable minimal residual disease is an independent prognostic factor in splenic marginal zone lymphoma.
Lyu, Rui; Wang, Tingyu; Wang, Yi; Xiong, Wenjie; Wang, Huijun; Yan, Yuting; Wang, Qi; Liu, Wei; An, Gang; Huang, Wenyang; Sui, Weiwei; Xu, Yan; Zou, Dehui; Wang, Jianxiang; Qiu, Lugui; Yi, Shuhua.
Affiliation
  • Lyu R; State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, National Clinical Research Center for Hematological Disorders, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • Wang T; State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, National Clinical Research Center for Hematological Disorders, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • Wang Y; State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, National Clinical Research Center for Hematological Disorders, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • Xiong W; State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, National Clinical Research Center for Hematological Disorders, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • Wang H; State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, National Clinical Research Center for Hematological Disorders, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • Yan Y; State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, National Clinical Research Center for Hematological Disorders, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • Wang Q; State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, National Clinical Research Center for Hematological Disorders, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • Liu W; State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, National Clinical Research Center for Hematological Disorders, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • An G; State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, National Clinical Research Center for Hematological Disorders, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • Huang W; State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, National Clinical Research Center for Hematological Disorders, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • Sui W; State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, National Clinical Research Center for Hematological Disorders, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • Xu Y; State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, National Clinical Research Center for Hematological Disorders, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • Zou D; State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, National Clinical Research Center for Hematological Disorders, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • Wang J; State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, National Clinical Research Center for Hematological Disorders, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • Qiu L; State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, National Clinical Research Center for Hematological Disorders, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • Yi S; State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, National Clinical Research Center for Hematological Disorders, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
Br J Haematol ; 194(5): 862-869, 2021 09.
Article in En | MEDLINE | ID: mdl-34328213
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Splenic Neoplasms / Neoplasm, Residual / Lymphoma, B-Cell, Marginal Zone Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Br J Haematol Year: 2021 Type: Article Affiliation country: China
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Splenic Neoplasms / Neoplasm, Residual / Lymphoma, B-Cell, Marginal Zone Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Br J Haematol Year: 2021 Type: Article Affiliation country: China